Update is adaptation of 2019 recommendations from Federal Advisory Committee AMERICAN CANCER SOCIETY The American Cancer Society (ACS) has updated its guideline for HPV vaccination, adapting a 2019 update from the Federal Advisory Committee on Immunization Practices (ACIP). The ACS first issued a guideline for routine use of the HPV vaccine in 2007, with an...
Tag: <span>T-cell population</span>
Post
HPTN 083 study demonstrates superiority of cabotegravir for the prevention of HIV
Both cabotegravir and oral tenofovir/emtricitabine (TDF/FTC) have high efficacy for pre-exposure prophylaxis (PrEP) DURHAM, N.C. – Researchers from the HIV Prevention Trials Network (HPTN) announced today that the HPTN 083 clinical trial showed that a pre-exposure prophylaxis (PrEP) regimen containing long-acting cabotegravir (CAB LA) injected once every 8 weeks was superior to daily oral tenofovir/emtricitabine...
Post
Moving the diagosis of rheumatic diseases into the era of precision medicine
by Delthia Ricks , Medical Xpress Many rheumatic conditions develop slowly and initially have inflammatory arthritis as the first sign that something is amiss. The trouble with such close similarity is the difficulty that clinicians have differentiating one condition from another in the early stages of the disease process. Dr. Rachel Knevel and colleagues at...
Post
COVID-19: the number of antibodies neutralizing the virus decreases after six weeks
Neutralizing antibodies are thought to be key to the development of an efficient vaccine against SARS-CoV-2. Researchers at the University of Montreal Hospital Research Centre (CRCHUM) indicate that ensuring their presence over long periods of time might be required. “Our study shows that more than six infected people in ten generated neutralizing antibodies in only...
Post
Biologists find a way to boost intestinal stem cell populations
Study suggests that stimulating stem cells may protect the gastrointestinal tract from age-related disease. MASSACHUSETTS INSTITUTE OF TECHNOLOGY CAMBRIDGE, MA — Cells that line the intestinal tract are replaced every few days, a high rate of turnover that relies on a healthy population of intestinal stem cells. MIT and University of Tokyo biologists have now...
Post
A new T-cell population for cancer immunotherapy
Scientists at the University of Basel in Switzerland have, for the first time, described a new T cell population that can recognize and kill tumor cells. The open access journal eLife has published the results. T lymphocytes (short T cells) are a special type of cells that recognize germs and protect our body from infections. Their second important...